DK3373945T3 - En oral stof-formulering omfattende silybin - Google Patents
En oral stof-formulering omfattende silybin Download PDFInfo
- Publication number
- DK3373945T3 DK3373945T3 DK16808920.9T DK16808920T DK3373945T3 DK 3373945 T3 DK3373945 T3 DK 3373945T3 DK 16808920 T DK16808920 T DK 16808920T DK 3373945 T3 DK3373945 T3 DK 3373945T3
- Authority
- DK
- Denmark
- Prior art keywords
- silybine
- formulation including
- substance formulation
- oral substance
- oral
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITUB2015A005532A ITUB20155532A1 (it) | 2015-11-12 | 2015-11-12 | Formulazione farmaceutica orale comprendente silibina |
| PCT/EP2016/077246 WO2017081140A1 (en) | 2015-11-12 | 2016-11-10 | An oral drug formulation comprising silybin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3373945T3 true DK3373945T3 (da) | 2020-11-02 |
Family
ID=55359667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16808920.9T DK3373945T3 (da) | 2015-11-12 | 2016-11-10 | En oral stof-formulering omfattende silybin |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3373945B1 (da) |
| DK (1) | DK3373945T3 (da) |
| ES (1) | ES2827999T3 (da) |
| HU (1) | HUE052455T2 (da) |
| IT (1) | ITUB20155532A1 (da) |
| PL (1) | PL3373945T3 (da) |
| PT (1) | PT3373945T (da) |
| SG (1) | SG11201803865XA (da) |
| WO (1) | WO2017081140A1 (da) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1187687B (it) * | 1985-07-17 | 1987-12-23 | Inverni Della Beffa Spa | Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi |
| IT1215291B (it) * | 1985-07-17 | 1990-01-31 | Inverni Della Beffa Spa | Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche. |
| CN101926792A (zh) * | 2008-12-25 | 2010-12-29 | 天津康鸿医药科技发展有限公司 | 一种含有水飞蓟宾二偏琥珀酸酯的磷脂复合物、其制备方法和用途 |
| CN101953794B (zh) * | 2009-07-21 | 2014-05-14 | 天士力制药集团股份有限公司 | 一种水飞蓟宾注射剂及制备方法 |
| CN102228430B (zh) * | 2011-06-14 | 2015-12-09 | 中国中医科学院中药研究所 | 水飞蓟宾磷脂复合物的纳米混悬剂及其制备方法 |
| CN104887630A (zh) * | 2015-05-15 | 2015-09-09 | 大连理工大学 | 一种脂质体包覆脱氢水飞蓟宾磷脂复合物及其制备方法 |
-
2015
- 2015-11-12 IT ITUB2015A005532A patent/ITUB20155532A1/it unknown
-
2016
- 2016-11-10 PT PT168089209T patent/PT3373945T/pt unknown
- 2016-11-10 DK DK16808920.9T patent/DK3373945T3/da active
- 2016-11-10 EP EP16808920.9A patent/EP3373945B1/en active Active
- 2016-11-10 HU HUE16808920A patent/HUE052455T2/hu unknown
- 2016-11-10 PL PL16808920T patent/PL3373945T3/pl unknown
- 2016-11-10 SG SG11201803865XA patent/SG11201803865XA/en unknown
- 2016-11-10 ES ES16808920T patent/ES2827999T3/es active Active
- 2016-11-10 WO PCT/EP2016/077246 patent/WO2017081140A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ITUB20155532A1 (it) | 2017-05-12 |
| ES2827999T3 (es) | 2021-05-25 |
| WO2017081140A1 (en) | 2017-05-18 |
| EP3373945A1 (en) | 2018-09-19 |
| EP3373945B1 (en) | 2020-08-12 |
| PL3373945T3 (pl) | 2021-03-08 |
| HUE052455T2 (hu) | 2021-04-28 |
| SG11201803865XA (en) | 2018-06-28 |
| PT3373945T (pt) | 2020-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268697A (en) | Formulations | |
| DK3688162T3 (da) | Formuleringer | |
| EP3490539A4 (en) | NEW ORAL FORMULATION. | |
| EP3513809A4 (en) | MEDICAL COMPOSITION | |
| EP3337502A4 (en) | STABLE ANTI-IFNAR1 FORMULATION | |
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| IL257531A (en) | Therapeutic combinations comprising anti-folr1 immunoconjugates | |
| PT4070788T (pt) | Formulações farmacêuticas | |
| DK3089741T3 (da) | Farmaceutiske sammensætninger omfattende azd9291 | |
| DK3655038T3 (da) | Farmaceutisk sammensætning | |
| MA42303A (fr) | Formulations pharmaceutiques | |
| PL3703518T3 (pl) | Formulacja ulegająca aerozolowaniu | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| EP3364945C0 (en) | SOLID FORMULATION | |
| DK3436120T3 (da) | Oral medicinsk indretning | |
| EP3454847A4 (en) | IMPROVED DRUG FORMULATIONS | |
| DK3583943T3 (da) | Farmaceutisk sammensætning | |
| EP3383371C0 (en) | PHARMACEUTICAL FORMULATION | |
| HUE063178T2 (hu) | Kopanlizib formulációi | |
| DK3280447T3 (da) | Farmaceutiske formuleringer | |
| DK3316856T3 (da) | Blandede formuleringer | |
| IL272167A (en) | Hemopexin formulations | |
| SI3173071T1 (sl) | Formulacija maropitanta | |
| EP3337463A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| DK3601277T3 (da) | Farmaceutisk formulering |